Thank you for subscribing!
Finfeed Archived Sep 04, 2019
Immuron’s (ASX:IMC) share price has surged on the back of extremely promising clinical results.
Finfeed Archived Sep 02, 2019
Travelan is Immuron’s (ASX:IMC) over-the-counter gastrointestinal and digestive health supplement, and global sales increased by 29.5% year-on-year in fiscal 2019 to $2.39 million.
Finfeed Archived Jul 25, 2019
Queenstown, the New Zealand extreme sport mecca, hosts the annual Bioshares Biotech Summit, gathering together some of the best long-standing and emerging biotech companies in the country to talk all things trials, tribulations and potential cures for cancer.
Finfeed Archived Jul 03, 2019
BPH Energy Ltd (ASX:BPH) has provided a promising update relating to further trials for the BARM System of investee Cortical Dynamics Ltd.
Get expert stock analysis direct in your inbox
Finfeed Archived Jun 12, 2019
Immuron Ltd (ASX:IMC; NASDQ:IMRN), has provided an extremely promising update on the company’s cooperative research and development agreements with the US Department of Defence, no doubt contributing to its strong share price performance on the back of this news.
Next Investors Archived Apr 08, 2019
Genetic Technologies (ASX:GTG) is a provider of world-leading genetic risk assessment test products.
Finfeed Archived Apr 02, 2019
Imugene Limited (ASX:IMU), a leading clinical stage immuno-oncology company, has today released new data on the Phase lb study of its HER-Vaxx cancer vaccine at the American Association for Cancer Research (AACR) 2019 Annual Meeting in Atlanta, Georgia.
Join Our Mailing List
